Chris Pulling

Mr. Pulling is CEO of the Ophthalmic Clinical-stage Medical Device start-up MicroOptx and has over 30 years experience in the medical device and clinical and regulatory fields. MicroOptx has raised approximately $24.5M in capital, including $17M in Q2-2019, and initiated a US pivotal clinical study in Q3-2019. Chris was previously CEO of The Integra Group, a contract medical research organization he founded in 2002 and later sold to the world's largest contract organization in the medical device sector. At that time, Integra was assisting over 400 pre-market medical device companies in all aspects of research and development. Chris was personally involved in over 30 original PMA approvals and even more 510(k) clearances. Prior to Integra, he built and ran Medtronic’s Cardiac Rhythm Management's Biostatistics function. Chris has an MS in Biostatistics from the University of Minnesota and was recently just the fourth recipient of the U of MN’s School of Public Health Alumni Innovator Award.